Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 42Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 1Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × dalpiciclib × Clear all
NCT06301438 2026-02-03

Dalpiciclib in HR+/HER2- ABC

RenJi Hospital

Recruiting
103 enrolled
Breast

Advanced Breast Cancer

NCT05578053 2025-09-11

Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

Hebei Medical University Fourth Hospital

Recruiting
420 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡